Total Payments
$232,323
2024 Payments
$11,884
Companies
76
Transactions
1,111
Medicare Patients
9,642
Medicare Billing
$983,581
Payment Breakdown by Category
Other$197,633 (85.1%)
Food & Beverage$24,084 (10.4%)
Consulting$6,129 (2.6%)
Travel$4,076 (1.8%)
Education$282.48 (0.1%)
Gifts$118.80 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $197,633 | 179 | 85.1% |
| Food and Beverage | $24,084 | 887 | 10.4% |
| Consulting Fee | $6,129 | 6 | 2.6% |
| Travel and Lodging | $4,076 | 23 | 1.8% |
| Education | $282.48 | 14 | 0.1% |
| Gift | $118.80 | 2 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $78,344 | 182 | $0 (2021) |
| Novo Nordisk Inc | $71,713 | 241 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $40,699 | 108 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $16,664 | 61 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $7,944 | 23 | $0 (2020) |
| Lilly USA, LLC | $5,000 | 59 | $0 (2024) |
| Mannkind Corporation | $1,321 | 51 | $0 (2024) |
| Dexcom, Inc. | $1,125 | 21 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,026 | 47 | $0 (2024) |
| Abbott Laboratories | $994.02 | 23 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $11,884 | 118 | Novo Nordisk Inc ($9,242) |
| 2023 | $8,087 | 111 | Novo Nordisk Inc ($5,091) |
| 2022 | $18,056 | 127 | Novo Nordisk Inc ($14,962) |
| 2021 | $15,235 | 101 | Novo Nordisk Inc ($13,581) |
| 2020 | $17,164 | 96 | Novo Nordisk Inc ($11,249) |
| 2019 | $46,297 | 176 | Janssen Pharmaceuticals, Inc ($25,361) |
| 2018 | $56,109 | 186 | Janssen Pharmaceuticals, Inc ($27,331) |
| 2017 | $59,492 | 196 | SANOFI-AVENTIS U.S. LLC ($24,077) |
All Payment Transactions
1,111 individual payment records from CMS Open Payments — Page 1 of 45
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $94.37 | General |
| Category: Insulin Pump | ||||||
| 12/17/2024 | Neurocrine Biosciences, Inc. | — | Food and Beverage | In-kind items and services | $32.65 | General |
| 12/16/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.95 | General |
| Category: Respiratory | ||||||
| 12/12/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $115.54 | General |
| Category: Endocrinology | ||||||
| 12/05/2024 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Food and Beverage | In-kind items and services | $23.37 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
| 12/05/2024 | Mannkind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $8.08 | General |
| Category: DIABETES MEDICINE | ||||||
| 12/04/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $25.60 | General |
| Category: Diabetes | ||||||
| 12/02/2024 | Mannkind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $25.61 | General |
| Category: DIABETES MEDICINE | ||||||
| 11/26/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $28.07 | General |
| Category: DIABETES | ||||||
| 11/19/2024 | BETA BIONICS, INC. | iLet Bionic Pancreas (Device), iLet Bionic Pancreas, iLet Bionic Pancreas | Food and Beverage | In-kind items and services | $20.38 | General |
| Category: Automated insulin delivery system | ||||||
| 11/15/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $107.02 | General |
| 11/11/2024 | Ultragenyx Pharmaceutical Inc. | Crysvita (Drug) | Food and Beverage | In-kind items and services | $23.73 | General |
| Category: XLH Metabolic Bone Disorder | ||||||
| 11/07/2024 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Food and Beverage | In-kind items and services | $24.69 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
| 11/04/2024 | Mannkind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $17.82 | General |
| Category: DIABETES MEDICINE | ||||||
| 10/31/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $19.09 | General |
| Category: Insulin Pump | ||||||
| 10/31/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $14.94 | General |
| Category: Diabetes Care | ||||||
| 10/29/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $29.19 | General |
| Category: DIABETES | ||||||
| 10/23/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $18.22 | General |
| Category: Neuromodulation | ||||||
| 10/23/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $5.36 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/22/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $105.23 | General |
| Category: Diabetes Care | ||||||
| 10/22/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $20.73 | General |
| Category: Diabetes Care | ||||||
| 10/22/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $19.62 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 10/22/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $11.90 | General |
| Category: Diabetes Care | ||||||
| 10/21/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.12 | General |
| Category: Respiratory | ||||||
| 10/15/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $23.84 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 2,189 | 5,233 | $593,529 | $229,798 |
| 2022 | 15 | 2,407 | 5,431 | $589,644 | $231,357 |
| 2021 | 14 | 2,505 | 5,835 | $567,442 | $266,643 |
| 2020 | 14 | 2,541 | 5,671 | $570,330 | $255,783 |
Total Patients
9,642
Total Services
22,170
Medicare Billing
$983,581
Procedure Codes
57
All Medicare Procedures & Services
57 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 202 | 956 | $109,116 | $62,820 | 57.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 419 | 806 | $137,020 | $52,892 | 38.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 232 | 515 | $113,300 | $50,045 | 44.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 186 | 209 | $46,121 | $22,638 | 49.1% |
| 83037 | Hemoglobin a1c level, by device for home use | Office | 2023 | 389 | 1,021 | $25,525 | $9,663 | 37.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 73 | 73 | $19,199 | $9,593 | 50.0% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2023 | 124 | 305 | $76,250 | $8,329 | 10.9% |
| 76536 | Ultrasound scan of head and neck soft tissue | Office | 2023 | 54 | 56 | $14,000 | $4,706 | 33.6% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 394 | 1,065 | $26,625 | $3,399 | 12.8% |
| 10005 | Fine needle aspiration biopsy using ultrasound guidance, first growth | Office | 2023 | 17 | 17 | $4,250 | $1,953 | 46.0% |
| 95249 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin | Office | 2023 | 25 | 33 | $6,600 | $1,645 | 24.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 22 | 25 | $2,750 | $1,178 | 42.8% |
| J3489 | Injection, zoledronic acid, 1 mg | Office | 2023 | 24 | 108 | $10,800 | $501.47 | 4.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 28 | 44 | $1,973 | $434.42 | 22.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 486 | 912 | $152,520 | $59,893 | 39.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 221 | 931 | $105,619 | $55,634 | 52.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 232 | 505 | $110,110 | $47,993 | 43.6% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 180 | 190 | $41,820 | $21,714 | 51.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 99 | 99 | $26,037 | $12,630 | 48.5% |
| 83037 | Hemoglobin a1c level, by device for home use | Office | 2022 | 451 | 1,138 | $28,450 | $10,852 | 38.1% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2022 | 98 | 204 | $51,000 | $5,725 | 11.2% |
| 76536 | Ultrasound scan of head and neck soft tissue | Office | 2022 | 58 | 59 | $14,750 | $5,697 | 38.6% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2022 | 461 | 1,132 | $28,300 | $3,646 | 12.9% |
| 95250 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with provider supplied equipment | Office | 2022 | 18 | 20 | $6,950 | $2,516 | 36.2% |
| 10005 | Fine needle aspiration biopsy using ultrasound guidance, first growth | Office | 2022 | 14 | 15 | $3,750 | $1,758 | 46.9% |
About Dr. Abdallah Altarshan, MD
Dr. Abdallah Altarshan, MD is a Internal Medicine healthcare provider based in Evergreen Park, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1174582811.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Abdallah Altarshan, MD has received a total of $232,323 in payments from pharmaceutical and medical device companies, with $11,884 received in 2024. These payments were reported across 1,111 transactions from 76 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($197,633).
As a Medicare-enrolled provider, Altarshan has provided services to 9,642 Medicare beneficiaries, totaling 22,170 services with total Medicare billing of $983,581. Data is available for 4 years (2020–2023), covering 57 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Diabetes & Metabolism
- Location Evergreen Park, IL
- Active Since 03/21/2006
- Last Updated 03/18/2022
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1174582811
Products in Payments
- INVOKANA (Drug) $77,788
- Ozempic (Drug) $27,069
- SOLIQUA (Drug) $25,004
- JARDIANCE (Drug) $20,571
- Rybelsus (Drug) $20,020
- RYBELSUS (Drug) $13,562
- TOUJEO (Drug) $12,528
- Tresiba (Drug) $6,034
- STEGLATRO (Drug) $5,565
- DISEASE STATE (Drug) $2,374
- AFREZZA (Drug) $1,321
- Omnipod (Device) $985.37
- FARXIGA (Drug) $920.85
- Korlym (Drug) $861.56
- FREESTYLE LIBRE 3 (Device) $626.83
- Dexcom G6 Transmitter (Medical Supply) $568.33
- XARELTO (Drug) $549.69
- MOUNJARO (Drug) $493.36
- Victoza (Drug) $427.33
- BPRO BT AMBULATORY BLOOD PRESSURE MONITORING SYSTEM (Device) $394.99
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Evergreen Park
Dr. Mohammad Tarek Kabbany, M.d, M.D
Internal Medicine — Payments: $19,253
Internal Medicine $19,253
Dr. Syed Moeed, M.d, M.D
Internal Medicine — Payments: $7,514
Internal Medicine $7,514
Mohammad Razzaque, M.d, M.D
Internal Medicine — Payments: $6,592
Internal Medicine $6,592
Satwant Kingra, Md, MD
Internal Medicine — Payments: $5,760
Internal Medicine $5,760
Dr. Hamdi Khilfeh, M.d, M.D
Internal Medicine — Payments: $5,168
Internal Medicine $5,168
Syed Mohsin, M.d, M.D
Internal Medicine — Payments: $4,460
Internal Medicine $4,460